213 related articles for article (PubMed ID: 23092091)
41. CXC chemokine expression profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.
El-Asrar AM; Al-Obeidan SS; Kangave D; Geboes K; Opdenakker G; Van Damme J; Struyf S
Immunobiology; 2011 Sep; 216(9):1004-9. PubMed ID: 21531038
[TBL] [Abstract][Full Text] [Related]
42. [Uveitis].
Correia J; Barbosa P; Paiva P; Ferreira A; Vasconcelos C; Leão B; Marques M; Torres P; Branco H; Da Silva BM
Acta Med Port; 1998 Oct; 11(10):877-81. PubMed ID: 10021782
[TBL] [Abstract][Full Text] [Related]
43. [A multicenter clinico-epidemiological study of HTLV-I associated uveitis].
Nakao K; Ohba N; Inomata H; Yamamoto M; Ohshima K; Hayashi H; Akiya S; Ibi K; Mochizuki M; Yoshimura K
Nippon Ganka Gakkai Zasshi; 1994 Sep; 98(9):858-65. PubMed ID: 7976846
[TBL] [Abstract][Full Text] [Related]
44. Vogt-Koyanagi-Harada's disease in Brazil.
Belfort Junior R; Nishi M; Hayashi S; Abreu MT; Petrilli AM; Plut RC
Jpn J Ophthalmol; 1988; 32(3):344-7. PubMed ID: 3230721
[TBL] [Abstract][Full Text] [Related]
45. Analysis of HLA Profiles in 390 Uveitis Cases: Insights into Clinical Presentations.
Li S; Yan L; Li M; Fan N
Altern Ther Health Med; 2023 Nov; 29(8):717-721. PubMed ID: 37708541
[TBL] [Abstract][Full Text] [Related]
46. The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.
Mishima S; Masuda K; Izawa Y; Mochizuki M; Namba K
Trans Am Ophthalmol Soc; 1979; 77():225-79. PubMed ID: 397657
[TBL] [Abstract][Full Text] [Related]
47. Clinical Patterns and Causes of Intraocular Inflammation in a Uveitis Patient Cohort from Egypt.
Amin RM; Goweida M; Bedda A; Kamel A; Radwan A
Ocul Immunol Inflamm; 2019; 27(6):859-867. PubMed ID: 27782772
[No Abstract] [Full Text] [Related]
48. Clinical studies of Vogt-Koyanagi-Harada's disease.
Ohno S; Minakawa R; Matsuda H
Jpn J Ophthalmol; 1988; 32(3):334-43. PubMed ID: 3230720
[TBL] [Abstract][Full Text] [Related]
49. Clinical and etiologic characteristics of de novo uveitis in patients aged 60 years and above: experience of a French tertiary center.
Grumet P; Kerever S; Gilbert T; Kodjikian L; Gerfaud-Valentin M; De Parisot A; Jamilloux Y; Sève P
Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1971-1979. PubMed ID: 31312906
[TBL] [Abstract][Full Text] [Related]
50. Characteristics of endogenous uveitis in Hokkaido, Japan.
Kotake S; Furudate N; Sasamoto Y; Yoshikawa K; Goda C; Matsuda H
Graefes Arch Clin Exp Ophthalmol; 1997 Jan; 235(1):5-9. PubMed ID: 9034835
[TBL] [Abstract][Full Text] [Related]
51. Pattern-reversal visual evoked potentials in patients with human T-lymphotropic virus type 1 uveitis.
Yukawa E; Urano T; Nakahara M; Miyata K; Matsuura T; Taketani F; Hara Y; Mochizuki M
Curr Eye Res; 2006 Jan; 31(1):37-42. PubMed ID: 16421018
[TBL] [Abstract][Full Text] [Related]
52. A clinical evaluation of uveitis-associated secondary glaucoma.
Takahashi T; Ohtani S; Miyata K; Miyata N; Shirato S; Mochizuki M
Jpn J Ophthalmol; 2002; 46(5):556-62. PubMed ID: 12457916
[TBL] [Abstract][Full Text] [Related]
53. Causes of uveitis at The Eye Center in Saudi Arabia: a retrospective review.
Islam SM; Tabbara KF
Ophthalmic Epidemiol; 2002 Oct; 9(4):239-49. PubMed ID: 12187422
[TBL] [Abstract][Full Text] [Related]
54. Pattern of Uveitis at a Tertiary Eye Hospital in Eastern Province of Saudi Arabia and Comparison with Local Literature.
Alarfaj G; Alahmadi G; Alabdullah H; Al-Khars W; Al-Hammad F
Ocul Immunol Inflamm; 2023 Nov; 31(9):1837-1841. PubMed ID: 36745705
[TBL] [Abstract][Full Text] [Related]
55. [A statistic study of Vogt-Koyanagi-Harada syndrome (author's transl)].
Fujioka T; Fukuda M; Okinami S
Nippon Ganka Gakkai Zasshi; 1980 Nov; 84(11):1979-82. PubMed ID: 7246357
[No Abstract] [Full Text] [Related]
56. Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey.
Sungur G; Hazirolan D; Bilgin G
Ocul Immunol Inflamm; 2013 Dec; 21(6):455-61. PubMed ID: 23909887
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of HTLV-I-associated uveitis in the Kanto Plain, Japan.
Ishioka M; Goto K; Nakamura S; Watanabe N; Uchio E; Saeki K; Ohno S
Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):476-8. PubMed ID: 8537021
[TBL] [Abstract][Full Text] [Related]
58. Epidemiology of Uveitis, Caused by HTLV-1, Toxoplasmosis, and Tuberculosis; the Three Leading Causes of Endemic Infectious Uveitis in Japan.
Takeda A; Ishibashi T; Sonoda KH
Ocul Immunol Inflamm; 2017; 25(sup1):S19-S23. PubMed ID: 27925851
[TBL] [Abstract][Full Text] [Related]
59. [Uveitis in human T-lymphotropic virus type I (HTLV-I) carriers--1. A seroepidemiological study].
Shirao M; Yoshimura K; Mochizuki M; Araki S; Miyata N; Yamaguchi K; Takatsuki K; Watanabe T; Mori S; Tajima K
Nippon Ganka Gakkai Zasshi; 1993 Jun; 97(6):726-32. PubMed ID: 8328341
[TBL] [Abstract][Full Text] [Related]
60. FK506 treatment of noninfectious uveitis.
Ishioka M; Ohno S; Nakamura S; Isobe K; Watanabe N; Ishigatsubo Y; Tanaka S
Am J Ophthalmol; 1994 Dec; 118(6):723-9. PubMed ID: 7526689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
